Curtis Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$794K Hold
6,600
0.17% 71
2025
Q4
$695K Hold
6,600
0.15% 74
2025
Q3
$554K Buy
+6,600
New +$544K 0.13% 74
2024
Q1
Sell
-3,269
Closed -$356K 97
2023
Q4
$356K Hold
3,269
0.16% 70
2023
Q3
$337K Sell
3,269
-500
-13% -$53.9K 0.11% 68
2023
Q2
$435K Hold
3,769
0.14% 64
2023
Q1
$401K Sell
3,769
-100
-3% -$10.8K 0.15% 62
2022
Q4
$429K Sell
3,869
-1,431
-27% -$146K 0.17% 56
2022
Q3
$456K Sell
5,300
-500
-9% -$44.6K 0.19% 55
2022
Q2
$529K Sell
5,800
-200
-3% -$17.7K 0.21% 53
2022
Q1
$492K Hold
6,000
0.17% 51
2021
Q4
$460K Sell
6,000
-133
-2% -$10.6K 0.15% 57
2021
Q3
$461K Sell
6,133
-267
-4% -$20.3K 0.17% 49
2021
Q2
$498K Sell
6,400
-517
-7% -$38.5K 0.22% 49
2021
Q1
$509K Buy
6,917
+3,354
+94% +$247K 0.23% 52
2020
Q4
$278K Hold
3,563
0.14% 54
2020
Q3
$282K Sell
3,563
-419
-11% -$32.8K 0.17% 51
2020
Q2
$294K Hold
3,982
0.21% 45
2020
Q1
$292K Sell
3,982
-420
-10% -$33K 0.19% 41
2019
Q4
$382K Buy
+4,402
New +$362K 0.22% 40

Other funds holding MRK

Curtis Advisory Group's MRK Position: Q1 2026 in Review

Curtis Advisory Group held its Merck (MRK) position steady in Q1 2026 at 6,600 shares worth $794K. The position accounts for 0.17% of the portfolio, ranked #71.

Curtis Advisory Group first reported a position in MRK in Q4 2019 and has held it in 20 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Curtis Advisory Group held 6,600 shares of Merck worth $794K as of Q1 2026.
  • Curtis Advisory Group left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.17% of Curtis Advisory Group's portfolio in Q1 2026, its #71 holding.
  • Curtis Advisory Group first reported a position in Merck in Q4 2019 and has held it in 20 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Curtis Advisory Group's 13F filing for Q1 2026, filed 8 May 2026.